Diagnosis, Pathology, Treatment, and Nursing Considerations for Cancer of Unknown Primary

被引：2

作者：

Winkeljohn, Debra L. ^{[1
]}

机构：

[1] Hematol Oncol Asociates, Albuquerque, NM USA

来源：

CLINICAL JOURNAL OF ONCOLOGY NURSING | 2009年 / 13卷 / 03期

关键词：

PRIMARY SITE; RESEARCH-NETWORK;

D O I：

10.1188/09.CJON.273-275

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

收藏

页码：273 / 275

页数：3

相关论文

共 12 条

[1]

[Anonymous], 2008, Cancer Facts Figures 2008

[2]

[Anonymous], NCCN PRACT GUID ONC

[3]

*CANC NET, 2008, UNKN PRIM

[4] Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: A Minnie Pearl Cancer Research Network study [J].

Greco, FA ;

Burris, HA ;

Litchy, S ;

Barton, JH ;

Bradof, JE ;

Richards, P ;

Scullin, DC ;

Erland, JB ;

Morrissey, LH ;

Hainsworth, JD .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1651-1656

[5]

HAINSWORTH JD, 2008, UPTODATE ADENOCARCIN

[6]

HAINSWORTH JD, 2008, UPTODATE OVERVIEW CL

[7] Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: The Minnie Pearl Cancer Research Network [J].

Hainsworth, John D. ;

Spigel, David R. ;

Farley, Cindy ;

Thompson, Dana S. ;

Shipley, Dianna L. ;

Greco, F. Anthony .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1747-1752

[8]

*KRAS INF, 2009, KRAS HIST

[9]

*MED DICT ONL, 2009, C MYC GENE

[10]

*NAT CANC I, 2009, C KIT RECEPTOR DICT